Health Care & Life Sciences

BioCrossroads seed fund makes first investments

January 10, 2013
Local startups Esanex Inc. and Algaeon Inc. have received $500,000 and $250,000, respectively, from Indiana Seed Fund II, BioCrossroads' second fund to help fledgling life sciences companies.
More

Lilly settles with four sisters in DES cancer case

January 9, 2013
Associated Press
Four sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s reached a settlement Wednesday with Eli Lilly and Co. in the first of scores of similar claims around the country to go to trial.
More

WellPoint draws criticism for California rate increase

January 9, 2013
Bloomberg News
WellPoint Inc.’s plan to raise the rates for small employers in California was criticized as unreasonable by the state insurance commissioner, who said customers are being charged this year to cover U.S. health-law fees that won’t begin until 2014.
More

Drug sold by Lilly caused cancer, women claim at Boston trial

January 8, 2013
Associated Press
In opening statements Tuesday, a lawyer for Indianapolis-based Lilly told the jury there is no evidence the synthetic estrogen known as DES causes breast cancer in the daughters of women who took it.
More

WellPoint says earnings could slightly exceed expectations

January 8, 2013
Associated Press
WellPoint Inc. said Tuesday that it expects 2012 earnings at the high end or slightly above a range that the health insurer reaffirmed last month.
More

Fiscal cliff deal threatens Indiana co-op health plan

January 7, 2013
J.K. Wall
Last week’s fiscal cliff bargain in Congress dealt a potentially fatal blow to a new health insurance plan, called Remedy Indiana, that was set to launch this year.
More

Spotlight falls on IU Health for flu shot firings

January 7, 2013
J.K. Wall
Indiana University Health got national attention last week for its decision to dismiss eight employees for refusing to get a flu vaccination. The Indianapolis-based hospital system fired three nurses and five other employees from its IU Health Goshen Hospital.
More

Big drug deals expected to return in 2013

January 7, 2013
Bloomberg News
Pharmaceutical companies including Pfizer Inc., Bristol-Myers Squibb Co. and Eli Lilly and Co. could be ready to start making major acquisitions again.
More

Decline in fitness club memberships pushes NIFS into arms of seniorsRestricted Content

January 5, 2013
J.K. Wall
Health club on campus of IUPUI makes up for lost revenue by managing fitness and wellness programs for retirement communities.
More

Stock buyback continues at CNORestricted Content

January 5, 2013
 IBJ Staff
The Carmel-based owner of Bankers Life and other insurance companies has seen its stock rise as it restructures debt.
More

Lilly's 2013 profit forecast tops expectations

January 4, 2013
Associated Press
Eli Lilly and Co. forecasts its 2013 earnings will grow more than Wall Street expects even though the drugmaker will lose U.S. patent protection for two more key products in the new year.
More

Trial set to begin over pregnancy drug sold by Lilly

January 3, 2013
Associated Press
Four sisters diagnosed with breast cancer are suing Eli Lilly and Co., a former maker of DES, or diethylstilbestrol, a drug taken by their mother in the 1950s when she was pregnant. It could be the first of scores of such trials over the drug.
More

Women’s physician building targeted for foreclosure

December 21, 2012
A lawsuit from the lender claims that Women's Physician Group still owes $8.7 million on a $9 million loan it received for a northwest-side building.
More

Lilly agrees to pay $29.4M to settle SEC bribery charges

December 20, 2012
J.K. Wall
According to a statement released by the SEC, Eli Lilly paid $6.5 million—and in some cases gave jewelry and spa treatments—to win government contracts in Brazil, China, Russia and Poland.
More

Indiana to receive nearly $793K in Amgen settlement

December 20, 2012
Associated Press
Amgen Inc. has agreed to pay Indiana nearly $793,000 as part of a larger settlement to resolve allegations it paid kickbacks to physicians who prescribed some of its drugs for unapproved uses.
More

Health care pricing service comes to Indy

December 17, 2012
J.K. Wall

Chicago-based OkCopay Inc. posts prices offered by Indianapolis health care providers, many of which have agreed to give cash-paying patients a price roughly equivalent to those charged to insured customers. The site also includes pricing information from health care providers that do not give cash-paying patients an additional break.

More

Lilly finds solace in new Alzheimer's study

December 17, 2012
J.K. Wall
Eli Lilly and Co. suffered a delay in its effort to bring an Alzheimer’s drug to market this month, but it also published new research that the pharmaceutical company thinks confirms it is on the right track.
More

IEDC seeks $30M fund to stoke life sciences firmsRestricted Content

December 15, 2012
Kathleen McLaughlin
The Indiana Economic Development Corp. is looking to renew its commitment to life sciences by creating a $30 million venture fund. The amount dedicated to one sector would be equal to the state’s allocation for all high-tech startups over the past two years.
More

State expects to extend Healthy Indiana Plan a year

December 14, 2012
Associated Press
The Centers for Medicare and Medicaid Services agreed to a waiver that would allow the state to continue the program unchanged for a year.
More

Actuarial firm plans expansion at Indy office

December 14, 2012
Milliman Inc. said it will add 26 jobs by 2017 and invest $2 million to install additional information technology equipment at its office in downtown's Chase Tower.
More

Apartments, shops planned for old Beech Grove hospital site

December 13, 2012
Dubbed Franciscan Place, the $20 million development will feature 150-plus senior-living apartments, shops and a restaurant in the old hospital. Work is expected to begin in February.
More

Lilly discontinues late-stage trial in rheumatoid arthritis

December 13, 2012
Bloomberg News
Eli Lilly and Co. said it discontinued a last-stage trial of experimental rheumatoid arthritis drug tabalumab for lack of efficacy. Lilly is still evaluating the drug in the two other late-stage studies.
More

WellPoint reaffirms 2012 earnings forecast

December 11, 2012
Associated Press
WellPoint Inc. is sticking with a 2012 earnings forecast that it had cut in July, and the nation's second-largest health insurer said it expects next year's earnings to be on par with this year's performance.
More

Report ranks Indiana among unhealthiest states

December 11, 2012
Associated Press
America's Health Rankings lists Indiana 41st in its annual review, which was released Tuesday. Obesity, sedentary habits, high smoking rates, low public health funding and air pollution contributed to Indiana's low rank.
More

Q&A

December 10, 2012
J.K. Wall
Muhammad Yasin began heading up social media marketing at Indianapolis-based HCC Medical Insurance Services LLC in early 2011. The company, which sells travel insurance and short-term medical insurance online, credits his work with tripling overall revenue in 2011 to more than $60 million and growing even more this year. Yasin, along with a steady stream of interns, manages nearly 50 social media accounts on Facebook, Twitter, Pinterest and YouTube, and has about 400,000 total followers. Collectively, HCC’s social media team produces 2,000 pieces of “content” every month—even though it operates in a highly regulated industry.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT